CAHNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends June 30
CARDINAL HEALTH INC
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 10-K on Aug 11, 2026
$252.65−1.41 (-0.55%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 34.9
- Dividend yield
- 0.81%
Share price
+$96.24 (+61.53%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
CARDINAL HEALTH INC grew revenue 14.2% to $254.25B over fiscal 2026. Operating income rose 14.9% to $2.61B, moving the operating margin from 1.0% to 1.0%. Free cash flow was $4.53B, up 144.6% from a year earlier.
Revenue
$254.25B
+14.2% vs. a year earlier
Operating income
$2.61B
+14.9% vs. a year earlier
Free cash flow
$4.53B
+144.6% vs. a year earlier
EPS, diluted
$7.23
+12.1% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- 34.9
- Price to sales
- –
- Price to book
- –
- Dividend yield
- 0.81%
- Free cash flow yield
- –
Fundamentals
- Revenue
- $254.25B
- Net income
- $1.71B
- EPS, diluted
- $7.23
- Free cash flow
- $4.53B
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$254.25B+14.2% YoY
Gross profit
$9.77B+19.7% YoY
Operating income
$2.61B+14.9% YoY
Net income
$1.71B+9.8% YoY
EPS, diluted
$7.23+12.1% YoY
Free cash flow
$4.53B+144.6% YoY
Reported period